Clinical Prediction Model of Obstructive Sleep Apnea at Mansoura University Hospitals
1 other identifier
observational
1,129
1 country
1
Brief Summary
Obstructive sleep apnea syndrome (OSAS)is a sleep breathing disorder manifested by complete apnea or partial hypopnea obstruction of the upper airway, which often remains undiagnosed and untreated (Kuczynski, W., 2019). These episodes, which should be more than 5 per hour and last at least 10 s, can lead to a sleep fragmentation and hypoxia (Huon, L.-K.A., 2017). OSAS predominantly affects 26% of individuals between 30 and 70 years in the U.S (apnea hypopnea index ≥5 events per hour) (Schwartz, M., 2018). Obstructive sleep apnea it is increasingly recognized as an independent risk factor for cardiac, neurologic, and perioperative morbidities. Yet this disorder remains undiagnosed in a substantial portion of our population. It is imperative for all physicians to remain vigilant in identifying patients with signs and symptoms consistent with OSA (Park, J. G., 2011). The test of hypothesis is to design a clinical prediction model of obstructive sleep apnea from collected data of the patients having symptoms of obstructive sleep apnea and the results of their sleep study
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 20, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 20, 2024
CompletedFirst Submitted
Initial submission to the registry
March 14, 2024
CompletedFirst Posted
Study publicly available on registry
March 22, 2024
CompletedMarch 22, 2024
March 1, 2024
1 year
March 14, 2024
March 20, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
The recorded data of all patients which include all their symptoms and comorbidities as well as their use of any regular medications will be collected.
The recorded data of all patients which include all their symptoms and comorbidities as well as their use of any regular medications will be collected.
1 year
Eligibility Criteria
Egyptian patients in sleep study unit, ChestDepartment Mansoura University Hospital, Egypt
You may qualify if:
- Patients aged \>18 years old
- presented with symptoms suggestive of OSA like excessive daytime sleepiness, snoring, nocturnal chocking and witnessed apnea
You may not qualify if:
- Patients with long-term use of medications known to affect sleep integrity Current
- alcohol or drug abuse
- History of psychosis
- Central sleep apnea syndromes
- Previous OSA surgery
- Other sleep disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mansoura University
Al Mansurah, Dakhlia, 050, Egypt
MeSH Terms
Conditions
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer of chest medicine
Study Record Dates
First Submitted
March 14, 2024
First Posted
March 22, 2024
Study Start
October 20, 2022
Primary Completion
October 20, 2023
Study Completion
February 20, 2024
Last Updated
March 22, 2024
Record last verified: 2024-03